GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Accounts Payable & Accrued Expense

Henan Lingrui Pharmaceutical Co (SHSE:600285) Accounts Payable & Accrued Expense : ¥1,809 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Accounts Payable & Accrued Expense?

Henan Lingrui Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥1,634 Mil) to Dec. 2023 (¥1,595 Mil) but then increased from Dec. 2023 (¥1,595 Mil) to Mar. 2024 (¥1,809 Mil).

Henan Lingrui Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥1,197 Mil) to Dec. 2022 (¥1,412 Mil) and increased from Dec. 2022 (¥1,412 Mil) to Dec. 2023 (¥1,595 Mil).

Henan Lingrui Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 801.71 921.92 1,196.82 1,412.33 1,595.31

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,513.89 1,569.28 1,634.23 1,595.31 1,808.90

Henan Lingrui Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
SZSE:300026 SHSE:600420 SZSE:300723 SZSE:002675 SZSE:002399 SHSE:600211 SHSE:600557 SHSE:600572 SZSE:300705 SZSE:300199 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA TSE:4507 VTRS NBIX XSWX:SDZ
Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Website
http://www.lingrui.com
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines